Genetic susceptibility analysis of a woman for BRCA1 and BRCA2, the genes linked to 90% of cases of early onset hereditary breast and ovarian cancers. Methodology: Sanger sequencing A BRCAssure(SM) clinical questionnaire should be submitted with specimens. Contact CMBP genetics services at 800-345-4363 to coordinate testing.